Covered recipient · General Payments record
VINCENT LUSCO
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$10,297.16
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $556.93 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $141.21 | 2 |
| DAVOL INC. | $133.81 | 1 |
| Kerecis Limited | $111.16 | 3 |
| Smith & Nephew, Inc. | $39.86 | 2 |
| Acera Surgical, Inc. | $35.06 | 2 |
| TELA Bio, Inc. | $27.24 | 2 |
| BAXTER HEALTHCARE | $21.29 | 1 |
| ORGANOGENESIS INC. | $17.96 | 1 |
| Integra LifeSciences Corporation | $15.47 | 1 |
| Medtronic, Inc. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acera Surgical, Inc. | $19.37 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152413622 | CMS |
| Acera Surgical, Inc. | $15.69 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152413620 | CMS |
| Baxter Healthcare | $21.29 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120629674 | CMS |
| Davol Inc. | $133.81 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127659009 | CMS |
| Integra LifeSciences Corporation | $15.47 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140139535 | CMS |
| Kerecis Limited | $45.69 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120099924 | CMS |
| Kerecis Limited | $39.85 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120108795 | CMS |
| Kerecis Limited | $25.62 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120100759 | CMS |
| Medtronic, Inc. | $13.87 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119353222 | CMS |
| Organogenesis Inc. | $17.96 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145437095 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.22 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151090969 | CMS |
| Phathom Pharmaceuticals, Inc. | $124.99 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151090971 | CMS |
| Smith+Nephew, Inc. | $26.46 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149569277 | CMS |
| Smith+Nephew, Inc. | $13.40 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149569275 | CMS |
| TELA Bio, Inc. | $10.47 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154272717 | CMS |
| TELA Bio, Inc. | $16.77 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154272719 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.